相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Automated Planning for Prostate Stereotactic Body Radiation Therapy on the 1.5 T MR-Linac
Stefania Naccarato et al.
ADVANCES IN RADIATION ONCOLOGY (2022)
Rectal spacer hydrogel in 1.5T MR-guided and daily adapted SBRT for prostate cancer: dosimetric analysis and preliminary patient-reported outcomes
Filippo Alongi et al.
BRITISH JOURNAL OF RADIOLOGY (2021)
Magnetic resonance image-guided adaptive stereotactic body radiotherapy for prostate cancer: preliminary results of outcome and toxicity
Gamze Ugurluer et al.
BRITISH JOURNAL OF RADIOLOGY (2021)
Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial
Ting Martin Ma et al.
BMC CANCER (2021)
Toxicity at 1 Year After Stereotactic Body Radiation Therapy in 3 Fractions for Localized Prostate Cancer
Alessandro Magli et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
MR-Guided Hypofractionated Radiotherapy: Current Emerging Data and Promising Perspectives for Localized Prostate Cancer
Francesco Cuccia et al.
CANCERS (2021)
ESTRO-ACROP recommendations on the clinical implementation of hybrid MR-linac systems in radiation oncology
Stefanie Corradini et al.
RADIOTHERAPY AND ONCOLOGY (2021)
Magnetic Resonance-guided Stereotactic Radiotherapy for Localized Prostate Cancer: Final Results on Patient-reported Outcomes of a Prospective Phase 2 Study
Shyama U. Tetar et al.
EUROPEAN UROLOGY ONCOLOGY (2021)
Hyprofractionated Versus Conventionally Fractionated Radiation Therapy for Patients with Intermediate- or High-Risk, Localized, Prostate Cancer: 7-Year Outcomes From the Randomized, Multicenter, Open-Label, Phase 3 HYPRO Trial
Kim C. de Vries et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment
Filippo Alongi et al.
RADIATION ONCOLOGY (2020)
Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy
Francesco Cuccia et al.
RADIATION ONCOLOGY (2020)
Adaptive SBRT by 1.5 T MR-linac for prostate cancer: On the accuracy of dose delivery in view of the prolonged session time
Ruggero Ruggieri et al.
PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS (2020)
MR-Guided Radiotherapy for Prostate Cancer
Boris R. Tocco et al.
FRONTIERS IN ONCOLOGY (2020)
Improving fiducial and prostate capsule visualization for radiotherapy planning using MRI
Angela U. Pathmanathan et al.
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS (2019)
MR-guidance in clinical reality: current treatment challenges and future perspectives
S. Corradini et al.
RADIATION ONCOLOGY (2019)
A Prospective Single-Arm Phase 2 Study of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for Prostate Cancer: Early Toxicity Results
Anna M. E. Bruynzeel et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
Anders Widmark et al.
LANCET (2019)
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial
Douglas H. Brand et al.
LANCET ONCOLOGY (2019)
Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer
Amar U. Kishan et al.
JAMA NETWORK OPEN (2019)
Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer
Charles N. Catton et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
David Dearnaley et al.
LANCET ONCOLOGY (2016)
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer
F. C. Hamdy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)